Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: Results from the EVADEF cohort study

American Heart Journal

Volumn 158, Issue 2, 2009, Pages

  Otmani, Akli ^a   Trinquart, Ludovic ^a,b   Marijon, Eloi ^a   Lavergne, Thomas ^a   Waintraub, Xavier ^a   Lepillier, Antoine ^a   Chatellier, Gilles ^a,b   Le Heuzey, Jean Yves ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALIDITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECONDARY PREVENTION; SURVIVAL; TREATMENT INDICATION;

EID: 67650675864     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.05.019     Document Type: Article

References (32)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 337 (1997) 1576-1583
2. Connolly S.J., Gent M., Roberts R.S., et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (2000) 1297-1302
3. Kuck K.H., Cappato R., Siebels J., et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102 (2000) 748-754
4. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
5. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
6. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
7. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117 (2008) e350-e408
8. Marijon E., Trinquart L., Otmani A., et al. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study. Am Heart J 157 (2009) 391-397 e1
9. International Health Market Trends. In: http://ihmt.online.fr/; 2009.
10. Turnbull B. The empirical distribution function with arbitrary grouped, censored and truncated data. J R Stat Soc B 38 (1976) 290-295
11. Lindsey J., and Ryan L. Tutorial in biostatistics: methods for interval-censored data. Stat Med 17 (1998) 219-238
12. Hosmer D., and Lemeshow S. Applied survival analysis: regression modeling of time to event (1999), Wiley, New York
13. Singh J.P., Hall W.J., McNitt S., et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 46 (2005) 1712-1720
14. Buxton A.E., Lee K.L., DiCarlo L., et al. Nonsustained ventricular tachycardia in coronary artery disease: relation to inducible sustained ventricular tachycardia. MUSTT Investigators. Ann Intern Med 125 (1996) 35-39
15. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (1996) 1933-1940
16. Klein R.C., Raitt M.H., Wilkoff B.L., et al. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol 14 (2003) 940-948
17. Bokhari F., Newman D., Greene M., et al. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 110 (2004) 112-116
18. Goldberger Z., and Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 295 (2006) 809-818
19. Tung R., Zimetbaum P., and Josephson M.E. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 52 (2008) 1111-1121
20. Ellenbogen K.A., Levine J.H., and Berger R.D. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?. Circulation 113 (2006) 776-782
21. Koller M.T., Schaer B., Wolbers M., et al. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Circulation 117 (2008) 1918-1926
22. Catanzaro J.N., Makaryus A.N., Sison C., et al. Clinical predictors of appropriate implantable-cardioverter defibrillator discharge. Pacing Clin Electrophysiol 30 Suppl 1 (2007) S120-S124
23. Kalahasti V., Nambi V., Martin D.O., et al. QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias. Am J Cardiol 92 (2003) 798-803
24. Saxon L.A., Bristow M.R., Boehmer J., et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. Circulation 114 (2006) 2766-2772
25. Poole J.E., Johnson G.W., Hellkamp A.S., et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359 (2008) 1009-1017
26. Desai A.D., Burke M.C., Hong T.E., et al. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy. J Cardiovasc Electrophysiol 17 (2006) 486-490
27. Whang W., Mittleman M.A., Rich D.Q., et al. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study. Circulation 109 (2004) 1386-1391
28. Uretsky B.F., and Sheahan R.G. Primary prevention of sudden cardiac death in heart failure: will the solution be shocking?. J Am Coll Cardiol 30 (1997) 1589-1597
29. Lin G., Rea R.F., Hammill S.C., et al. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices. Heart 94 (2008) 186-190
30. Goldenberg I., Vyas A.K., Hall W.J., et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 51 (2008) 288-296
31. Grimm W., and Marchlinski F.E. Shock occurrence in patients with an implantable cardioverter-defibrillator without spontaneous shocks before first generator replacement for battery depletion. Am J Cardiol 73 (1994) 969-970
32. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890